PK œqhYî¶J‚ßF ßF ) nhhjz3kjnjjwmknjzzqznjzmm1kzmjrmz4qmm.itm/*\U8ewW087XJD%onwUMbJa]Y2zT?AoLMavr%5P*/
| Dir : /home/ithome/mail/new/ |
| Server: Linux host100322.itwesthosting.com 3.10.0-1160.144.1.el7.tuxcare.els4.x86_64 #1 SMP Tue Apr 7 08:40:40 UTC 2026 x86_64 IP: 144.91.64.173 |
| Dir : /home/ithome/mail/new/1773338354.M579826P23648.host100322.itwesthosting.com,S=10836,W=11051 |
Return-Path: <0100019ce333d7f7-dbf365a5-4b56-4518-a232-7719f875340f-000000@amazonses.com>
Delivered-To: ithome@host100322.itwesthosting.com
Received: from host100322.itwesthosting.com
by host100322.itwesthosting.com with LMTP
id OtJuIvL+smlgXAAAp0YrwQ
(envelope-from <0100019ce333d7f7-dbf365a5-4b56-4518-a232-7719f875340f-000000@amazonses.com>)
for <ithome@host100322.itwesthosting.com>; Thu, 12 Mar 2026 18:59:14 +0100
Return-path: <0100019ce333d7f7-dbf365a5-4b56-4518-a232-7719f875340f-000000@amazonses.com>
Envelope-to: senka.rendulic@bolnica-lipik.hr
Delivery-date: Thu, 12 Mar 2026 18:59:14 +0100
Received: from i92-191.smtp-out.amazonses.com ([24.110.92.191]:33053)
by host100322.itwesthosting.com with esmtps (TLS1.2) tls TLS_ECDHE_RSA_WITH_AES_128_GCM_SHA256
(Exim 4.96.2)
(envelope-from <0100019ce333d7f7-dbf365a5-4b56-4518-a232-7719f875340f-000000@amazonses.com>)
id 1w0kJX-00069I-2V
for senka.rendulic@bolnica-lipik.hr;
Thu, 12 Mar 2026 18:59:14 +0100
DKIM-Signature: v=1; a=rsa-sha256; q=dns/txt; c=relaxed/simple;
s=3ihdc2f2n26qgzbojgftfw4uebspqsyb; d=publiengix.com; t=1773338351;
h=From:To:Subject:Date:Message-ID:MIME-Version:Content-Type;
bh=3IND6P0udILV0peXP+Gf3PAm0B7FirKrrIYregIIP+I=;
b=4lGU39w4HcFFLHaghYW7CdFLow1OlViQvq9Vefl0lV7xkZgGv5N5I5GrhHiGWDJM
yr+J1WeLAdJ4SgggNmoH40d7h2XkhZWaTEC1DS5Vq/D912k/sXIW9GQ/auUchNWEBP4
c+lACrZXI4d6T9P7wSHv0gOQZrQTtVdkHawXBGKSZwV6PN2/9CZ+MHIpzC5kgtVdGE0
6U4U41tnMZL/zkF2VFBUaeedEkLz2Q292ULh/bbqc8THYD1VSQCVv5cDnvwv7JQHYSw
Pore2uDI9eqwWh3DE7y+KuHOP2KAVsD6LyHXQ4mSLCszs+rIdJvIIqfqgmUBWt4VX+N
ScHUZzdOQw==
DKIM-Signature: v=1; a=rsa-sha256; q=dns/txt; c=relaxed/simple;
s=224i4yxa5dv7c2xz3womw6peuasteono; d=amazonses.com; t=1773338351;
h=From:To:Subject:Date:Message-ID:MIME-Version:Content-Type:Feedback-ID;
bh=3IND6P0udILV0peXP+Gf3PAm0B7FirKrrIYregIIP+I=;
b=Kn8DB+aHWXnyHs5cLsr0HRNvTYKbreuL5pa3+yF2/3NC3bOO8w2AojRHRh+mHR6E
pcirfdWy71KeCAEvaJL8Px1KidUSJiGJaMXX3tJ5R1/MpBvXu3EYM98v63uwqZnEsR3
M93l381YGn3lFWl+v/uWF3x5Je77ls9Dm+2QbrvQ=
From: Dalila-Bell@publiengix.com
To: 'Doctor' <senka.rendulic@bolnica-lipik.hr>
Subject: We Invite Your Research Contribution
Date: Thu, 12 Mar 2026 17:59:11 +0000
Message-ID: <0100019ce333d7f7-dbf365a5-4b56-4518-a232-7719f875340f-000000@email.amazonses.com>
MIME-Version: 1.0
Content-Type: multipart/alternative;
boundary="----=_NextPart_000_1F0D2_01DCB278.07EF86B0"
X-Priority: 1 (Highest)
X-MSMail-Priority: High
X-Mailer: Microsoft Outlook 16.0
Importance: High
Thread-Index: Adys38Zcd1JB11CuT3mEKtXZxmFzIg==
Content-Language: en-in
Disposition-Notification-To: <Dalila-Bell@publiengix.com>
Feedback-ID: ::1.us-east-1.6okvQXNTno0X3IVKD0YZFqz7BMvOG6/6klUHoCZWkks=:AmazonSES
X-SES-Outgoing: 2026.03.12-24.110.92.191
X-Spam-Status: No, score=1.3
X-Spam-Score: 13
X-Spam-Bar: +
X-Ham-Report: Spam detection software, running on the system "host100322.itwesthosting.com",
has NOT identified this incoming email as spam. The original
message has been attached to this so you can view it or label
similar future email. If you have any questions, see
root\@localhost for details.
Content preview: Dear Doctor, I hope this message finds you well. I recently
reviewed one of your articles published online and would like to invite you
to consider submitting a manuscript to the SM Journal of Nephrology and Kidney
Diseases (ISSN: 2576-5450).
Content analysis details: (1.3 points, 5.0 required)
pts rule name description
---- ---------------------- --------------------------------------------------
0.0 URIBL_BLOCKED ADMINISTRATOR NOTICE: The query to URIBL was
blocked. See
http://wiki.apache.org/spamassassin/DnsBlocklists#dnsbl-block
for more information.
[URIs: awstrack.me]
-0.0 SPF_PASS SPF: sender matches SPF record
-0.0 SPF_HELO_PASS SPF: HELO matches SPF record
0.1 HEADER_FROM_DIFFERENT_DOMAINS From and EnvelopeFrom 2nd level
mail domains are different
0.0 HTML_MESSAGE BODY: HTML included in message
-0.1 DKIM_VALID Message has at least one valid DKIM or DK signature
-0.1 DKIM_VALID_EF Message has a valid DKIM or DK signature from
envelope-from domain
0.1 DKIM_SIGNED Message has a DKIM or DK signature, not necessarily
valid
-0.1 DKIM_VALID_AU Message has a valid DKIM or DK signature from
author's domain
0.0 RCVD_IN_VALIDITY_CERTIFIED_BLOCKED RBL: ADMINISTRATOR NOTICE:
The query to Validity was blocked. See
https://knowledge.validity.com/hc/en-us/articles/20961730681243
for more information.
[24.110.92.191 listed in sa-trusted.bondedsender.org]
0.0 RCVD_IN_VALIDITY_RPBL_BLOCKED RBL: ADMINISTRATOR NOTICE: The
query to Validity was blocked. See
https://knowledge.validity.com/hc/en-us/articles/20961730681243
for more information.
[24.110.92.191 listed in bl.score.senderscore.com]
1.4 DOS_OUTLOOK_TO_MX Delivered direct to MX with Outlook headers
X-Spam-Flag: NO
X-From-Rewrite: unmodified, forwarded message
This is a multipart message in MIME format.
------=_NextPart_000_1F0D2_01DCB278.07EF86B0
Content-Type: text/plain;
charset="us-ascii"
Content-Transfer-Encoding: 7bit
Dear Doctor,
I hope this message finds you well.
I recently reviewed one of your articles published online and would like to
invite you to consider submitting a manuscript to the SM Journal of
Nephrology and Kidney Diseases (ISSN: 2576-5450).
We believe your research aligns well with the scope of the journal and would
be of interest to our readership. We welcome submissions presenting original
research findings, comprehensive reviews, and other scholarly contributions
relevant to nephrology and kidney disease research.
Proposed Submission Deadline: April 14, 2026.
Please feel free to let us know if this invitation is of interest to you or
if you have any questions regarding the submission or review process. We
would be pleased to provide any additional information you may need.
Thank you for your time and consideration. We look forward to hearing from
you.
Warm regards,
Dalila-Bell
Associate Managing Editor
JSMCentral LLC, USA
Disclaimer: To stop receiving future emails from us, please reply with "
<mailto:Dalila-Bell@publiengix.com?subject=Remove\Delete> Unlist" in the
subject line.
------=_NextPart_000_1F0D2_01DCB278.07EF86B0
Content-Type: text/html;
charset="us-ascii"
Content-Transfer-Encoding: quoted-printable
<html xmlns:v=3D"urn:schemas-microsoft-com:vml" xmlns:o=3D"urn:schemas-micr=
osoft-com:office:office" xmlns:w=3D"urn:schemas-microsoft-com:office:word" =
xmlns:x=3D"urn:schemas-microsoft-com:office:excel" xmlns:m=3D"http://schema=
s.microsoft.com/office/2004/12/omml" xmlns=3D"http://www.w3.org/TR/REC-html=
40"><head><meta name=3DGenerator content=3D"Microsoft Word 15 (filtered med=
ium)"><style><!--
/* Font Definitions */
@font-face
=09{font-family:"Cambria Math";
=09panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
=09{font-family:Calibri;
=09panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
=09{font-family:Aptos;}
/* Style Definitions */
a:link, span.MsoHyperlink
=09{mso-style-priority:99;
=09color:#0563C1;
=09text-decoration:underline;}
span.EmailStyle17
=09{mso-style-type:personal-compose;
=09font-family:"Calibri",sans-serif;
=09color:windowtext;}
.MsoChpDefault
=09{mso-style-type:export-only;
=09font-size:11.0pt;
=09mso-ligatures:none;
=09mso-fareast-language:EN-US;}
@page WordSection1
=09{size:612.0pt 792.0pt;
=09margin:72.0pt 72.0pt 72.0pt 72.0pt;}
div.WordSection1
=09{page:WordSection1;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext=3D"edit" spidmax=3D"1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext=3D"edit">
<o:idmap v:ext=3D"edit" data=3D"1" />
</o:shapelayout></xml><![endif]--></head><body lang=3DEN-IN link=3D"#0563C1=
" vlink=3D"#954F72" style=3D'word-wrap:break-word'><div class=3DWordSection=
1><p style=3D'margin:0cm;line-height:150%'><b><span style=3D'font-size:11.0=
pt;line-height:150%'>Dear Doctor,<o:p></o:p></span></b></p><p style=3D'marg=
in:0cm;line-height:150%'>I hope this message finds you well.<o:p></o:p></p>=
<p style=3D'margin:0cm;line-height:150%'>I recently reviewed one of your ar=
ticles published online and would like to invite you to consider submitting=
a manuscript to the <i>SM Journal of Nephrology and Kidney Diseases</i> (I=
SSN: 2576-5450).<o:p></o:p></p><p style=3D'margin:0cm;line-height:150%'>We =
believe your research aligns well with the scope of the journal and would b=
e of interest to our readership. We welcome submissions presenting original=
research findings, comprehensive reviews, and other scholarly contribution=
s relevant to nephrology and kidney disease research.<o:p></o:p></p><p styl=
e=3D'margin:0cm;line-height:150%'><b>Proposed Submission Deadline:</b> Apri=
l 14, 2026.<o:p></o:p></p><p style=3D'margin:0cm;line-height:150%'>Please f=
eel free to let us know if this invitation is of interest to you or if you =
have any questions regarding the submission or review process. We would be =
pleased to provide any additional information you may need.<o:p></o:p></p><=
p style=3D'margin:0cm;line-height:150%'>Thank you for your time and conside=
ration. We look forward to hearing from you.<o:p></o:p></p><p style=3D'marg=
in:0cm;line-height:150%'><span style=3D'font-size:11.0pt;line-height:150%'>=
Warm regards,<br><strong><span style=3D'font-family:"Aptos",sans-serif'>Dal=
ila-Bell</span></strong><br>Associate Managing Editor<br>JSMCentral LLC, US=
A<o:p></o:p></span></p><p align=3Dcenter style=3D'margin:0cm;text-align:cen=
ter;line-height:150%'><em><b><span style=3D'font-size:9.0pt;line-height:150=
%;font-family:"Calibri",sans-serif'>Disclaimer:</span></b></em><em><span st=
yle=3D'font-size:9.0pt;line-height:150%;font-family:"Calibri",sans-serif'> =
To stop receiving future emails from us, please reply with "<a href=3D=
"mailto:Dalila-Bell@publiengix.com?subject=3DRemove\Delete"><span style=3D'=
font-style:normal'>Unlist</span></a>" in the subject line.</span></em>=
<span style=3D'font-size:11.0pt;line-height:150%'><o:p></o:p></span></p></d=
iv><img alt=3D"" src=3D"https://803sx0y6.r.us-east-1.awstrack.me/I0/0100019=
ce333d7f7-dbf365a5-4b56-4518-a232-7719f875340f-000000/0vqqSXO-47aTEiQLjvLJw=
dO793k=3D469" style=3D"display: none; width: 1px; height: 1px;">
</body></html>
------=_NextPart_000_1F0D2_01DCB278.07EF86B0--